Immunogenicity 14221
Sample ID
3784
Response
Negative
Tumor Type
Melanoma
Gene Symbol
EXOC3
Transcript ID
NM_007277
HLA INFO
A*03:01
TCR INFO
No TCR info found!
Full length protein sequence (745 aa)
MKETD
1
REAVA
6
TAVQR
11
VAGML
16
QRPDQ
21
LDKVE
26
QYRRR
31
EARKK
36
ASVEA
41
RLKAA
46
IQSQL
51
DGVRT
56
GLSQL
61
HNALN
66
DVKDI
71
QQSLA
76
DVSKD
81
WRQSI
86
NTIES
91
LKDVK
96
DAVVQ
101
HSQLA
106
AAVEN
111
LKNIF
116
SVPEI
121
VRETQ
126
DLIEQ
131
GALLQ
136
AHRKL
141
MDLEC
146
SRDGL
151
MYEQY
156
RMDSG
161
NTRDM
166
TLIHG
171
YFGST
176
QGLSD
181
ELAKQ
186
LWMVL
191
QRSLV
196
TVRRD
201
PTLLV
206
SVVRI
211
IEREE
216
KIDRR
221
ILDRK
226
KQTGF
231
VPPGR
236
PKNWK
241
EKMFT
246
ILERT
251
VTTRI
256
EGTQA
261
DTRES
266
DKMWL
271
VRHLE
276
IIRKY
281
VLDDL
286
IVAKN
291
LMVQC
296
FPPHY
301
EIFKN
306
LLNMY
311
HQALS
316
TRMQD
321
LASED
326
LEANE
331
IVSLL
336
TWVLN
341
TYTST
346
EMMRN
351
VELAP
356
EVDVG
361
TLEPL
366
LSPHV
371
VSELL
376
DTYMS
381
TLTSN
386
IIAWL
391
RKALE
396
TDKKD
401
WVKET
406
EPEAD
411
QDGYY
416
QTTLP
421
AIVFQ
426
MFEQN
431
LQVAA
436
QISED
441
LKTKV
446
LVLCL
451
QQMNS
456
FLSRY
461
KDEAQ
466
LYKEE
471
HLRNR
476
QHPHC
481
YVQYM
486
IAIIN
491
NCQTF
496
KESIV
501
SLKRK
506
YLKNE
511
VEEGV
516
SPSQP
521
SMDGI
526
LDAIA
531
KEGCS
536
GLLEE
541
VFLDL
546
EQHLN
551
ELMTK
556
KWLLG
561
SNAVD
566
IICVT
571
VEDYF
576
NDFAK
581
IKKPY
586
KKRMT
591
AEAHR
596
RVVVE
601
YLRAV
606
MQKRI
611
SFRSP
616
EERKE
621
GAEKM
626
VREAE
631
QLRFL
636
FRKLA
641
SGFGE
646
DVDGY
651
CDTIV
656
AVAEV
661
IKLTD
666
PSLLY
671
LEVST
676
LVSKY
681
PDIRD
686
DHIGA
691
LLAVR
696
GDASR
701
DMKQT
706
IMETL
711
EQGPA
716
QASPS
721
YVPLF
726
KDIVV
731
PSLNV
736
AKLLK
741
Mutation Information
DNA mutation:
None
Peptide Range:
37 ~ 61
Mut AA position:
49 (13 in Wild Type peptide)
Alignment
Wild Type:
"ARKKASVEARLKAAIQSQLDGVRTG
||||||||||||.||||||||||||
Mutant:
ARKKASVEARLKVAIQSQLDGVRTG"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) EXOC3
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay